<code id='67F0A98ED3'></code><style id='67F0A98ED3'></style>
    • <acronym id='67F0A98ED3'></acronym>
      <center id='67F0A98ED3'><center id='67F0A98ED3'><tfoot id='67F0A98ED3'></tfoot></center><abbr id='67F0A98ED3'><dir id='67F0A98ED3'><tfoot id='67F0A98ED3'></tfoot><noframes id='67F0A98ED3'>

    • <optgroup id='67F0A98ED3'><strike id='67F0A98ED3'><sup id='67F0A98ED3'></sup></strike><code id='67F0A98ED3'></code></optgroup>
        1. <b id='67F0A98ED3'><label id='67F0A98ED3'><select id='67F0A98ED3'><dt id='67F0A98ED3'><span id='67F0A98ED3'></span></dt></select></label></b><u id='67F0A98ED3'></u>
          <i id='67F0A98ED3'><strike id='67F0A98ED3'><tt id='67F0A98ED3'><pre id='67F0A98ED3'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:95
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Medtronic CEO on promising devices for diabetes, hypertension
          Medtronic CEO on promising devices for diabetes, hypertension

          GeoffMartha,CEOofMedtronicCourtesyMedtronicAsoneofthelargestandoldestmedicaldevicecompaniesintheworl

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Meta's Zuckerberg and Chan on track to put $50 billion into science

          PriscillaChanandMarkZuckerbergonstage,virtually,atthe2023STATSummit.STATMarkZuckerbergandPriscillaCh